Article Details

Moderna Bolsters mRNA Oncology Business with Autolus' Proprietary Binders

Retrieved on: 2021-08-02 16:07:30

Tags for this article:

Click the tags to see associated articles and topics

Moderna Bolsters mRNA Oncology Business with Autolus' Proprietary Binders. View article details on hiswai:

Excerpt

Messenger RNA (mRNA)-focused Moderna has the rights to use Autolus' proprietary binders for four immunology targets. London-based Autolus ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up